Aristotle University Of Thessaloniki (AUTH)
Η επίδραση της θεραπείας με ανταγωνιστές του παράγοντα-α νέκρωσης των όγκων (TNF-α) στη δυσλειτουργία και τη βλάβη του ενδοθηλίου των αγγείων σε ασθενείς με ρευματοειδή αρθρίτιδα
Abstract
dc:descriptionObjectives: We sought to investigate whether long-term treatment with anti-TNFα agents can modulate vascular endothelial function and CCA-IMT in patients with rheumatoid arthritis (RA). Methods: 19 patients with RA on anti-TNFα treatment due to uncontrolled disease activity were prospectively studied. Patients more assessed at baseline and after 3 months for FMD and CCA-IMT. In 12 out of 19 patients the assessment was repeated at 18 months as well. Another small group of 6 patients with RA who were started on DMARDs for the first time were studied at baseline and after 3 months of treatment. Results: After 3 months of treatment with anti-TNFα half of the patients were responders according to the EULAR criteria, while FMD didn’t change significantly, but after 18 months FMD improved significantly. CCA-IMT and NMD remained stable throughout the 18 months of treatment, with anti-TNFα agents. Conclusions: After 18 months of treatment with anti-TNFα agents in patients with RA and no clinically overt cardiovascular disease, endothelial function (FMD) improved significantly, while CCA-IMT remained stable.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Siakka, Panagiota
- Σιάκκα, Παναγιώτα
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24746